- A subcommittee in the Iowa House of Representatives advanced House File 712, which would prohibit the sale and administration of vaccines in the state unless manufacturers waive certain liability protections granted under federal law. The bill specifically targets design defect claims, aiming to hold manufacturers accountable for injuries caused by inherently dangerous vaccine designs.
- The bill addresses concerns about the VICP, established under the 1986 National Childhood Vaccine Injury Act, which has compensated only 11,671 out of 24,602 claims over three decades. Critics argue the system inadequately serves the public and prioritizes corporate interests over accountability.
- The 2011 Supreme Court ruling in Bruesewitz v. Wyeth reinforced vaccine manufacturers’ immunity from design defect lawsuits, sparking criticism. Justice Sotomayor’s dissent highlighted the lack of incentives for manufacturers to improve vaccine designs, a concern echoed by advocates like Kim Mack Rosenberg of Children’s Health Defense.
- The bill reflects growing public skepticism toward vaccine mandates and liability protections, fueled by increased access to information and the COVID-19 pandemic. A 2022 Iowa poll showed only 34% support for mandatory school vaccinations, signaling a demand for greater accountability in the pharmaceutical industry.
- While supporters argue the bill would restore accountability and improve public trust, opponents warn it could lead to higher costs, reduced vaccine access, and unfounded injury claims. The bill has ignited a broader conversation about balancing corporate responsibility, public health, and individual rights, with potential implications for national vaccine policy.
In a bold move that could reshape the landscape of vaccine accountability, an Iowa House of Representatives subcommittee advanced a bill that would bar the sale and administration of vaccines in the state unless manufacturers waive some of the liability protections granted under federal law. House File 712, introduced by State Rep. Charley Thomson, aims to hold vaccine manufacturers accountable for injuries caused by design defects, a move that has sparked heated debate about corporate responsibility, public health, and individual rights.